A review of uses of health care utilization databases for epidemiologic research on therapeutics.
about
Approaches to canine health surveillanceEvaluating the impact of database heterogeneity on observational study resultsComparative safety of antidepressant agents for children and adolescents regarding suicidal actsValidation of chronic obstructive pulmonary disease (COPD) diagnoses in healthcare databases: a systematic review protocolInfluenza vaccination in the elderly: why are the overall benefits still hotly debated?A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disordersUseful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal DetectionWorkplace social capital and adherence to antihypertensive medication: a cohort studyBurden of diabetes mellitus estimated with a longitudinal population-based study using administrative databasesRisk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias ToolBig data are coming to psychiatry: a general introductionComparison of the Five Danish Regions Regarding Demographic Characteristics, Healthcare Utilization, and Medication Use--A Descriptive Cross-Sectional StudyNovel data-mining methodologies for adverse drug event discovery and analysisConsiderations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs.Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness researchActive safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring systemSupplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments.Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed PrescriptionsTreatment patterns for prostate cancer: comparison of Medicare claims data to medical record review.Official statistics and claims data records indicate non-response and recall bias within survey-based estimates of health care utilization in the older populationEvaluating the introduction of a computerized prior-authorization system on the completeness of drug exposure data.An inventory of European data sources for the long-term safety evaluation of methylphenidateApplication of electronic medical record data for health outcomes research: a review of recent literature.Caveats for the use of operational electronic health record data in comparative effectiveness research.Data quality assessment for comparative effectiveness research in distributed data networks.Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs.Validation of methods for assessing cardiovascular disease using electronic health data in a cohort of Veterans with diabetes.Validity of maternal and infant outcomes within nationwide Medicaid data.Sources of European drug consumption data at a country level.Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research.Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data.Orphan therapies: making best use of postmarket data.Big data and large sample size: a cautionary note on the potential for biasEstimation of biomarker distributions using laboratory data collected during routine delivery of medical care.Adherence to osteoporosis pharmacotherapy is underestimated using days supply values in electronic pharmacy claims data.Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan.Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project.Feasibility and utility of applications of the common data model to multiple, disparate observational health databases.No big data without small data: learning health care systems begin and end with the individual patient.Studies using Australia's Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: a systematic review of the published literature (1987-2013).
P2860
Q24288900-CA624EF8-367A-4A3A-AF04-794099618FB7Q24289210-079B9C78-F225-444F-AA95-11A4575EBD79Q24594810-4B60A0DA-D2CC-4F6C-A936-FCB1548C2B21Q24658536-58931C30-8EC8-49C6-9A0E-D2043887A6B5Q26770659-3E1C6E36-223E-4EC7-A00C-E8E344C963CDQ27000732-E059C455-3AE4-48EB-9731-8E09602B2416Q27335410-EAFDA1A6-4867-4D9C-A1AC-C75C94164234Q28477035-92157F19-6033-4AE4-91F5-F979E0ABCB77Q28542454-9686E048-9CCF-4FF5-B8F8-0E09381F7345Q28551188-054C62AC-250F-42F1-9129-9398ED5BE2EEQ28602477-F4D24C37-0E80-49DA-9C71-0823279B2EBEQ28606751-44C2A9A3-F485-4BD3-82B2-52BDD32F716CQ28681788-3CD87E4F-3A5F-472A-94B6-693BCAB14578Q30251866-99BCBA22-2173-4BDB-B958-7A88E4597C36Q30419845-5E968E69-9DC4-4E76-8343-92B0FF7453F5Q30573765-9A376D2B-1C15-492E-B4BF-D3C40BC9FCA5Q30578515-13812358-7B30-41FE-BB66-8617C9068080Q30579857-CEDA4A7E-0A2A-4FD1-A987-A4F7E0EE4E09Q30580698-3CA8A910-68C9-4C6F-A289-2D7AE54E90DEQ30584420-9C2BB724-5905-4EE3-8E94-ECF476753EECQ30597280-F7741C06-1B60-44DB-B513-9A7C91AB569EQ30603225-455D42C9-212B-4D4C-8AAE-918EF88D2C4BQ30613981-4B852E93-471A-44C0-B258-11AD41A8AFE9Q30649696-8FD6B776-6133-4D06-8DFB-74F3D78F0C01Q30651018-3C30D7A9-665C-498A-9283-9706389C0203Q30660067-5A786560-4827-4527-B4DF-AF9590A1A2B2Q30740532-1129A027-E5DA-4A57-B7DF-1DBB87B7B9A6Q30802786-DEC1F6F0-2EBF-44AD-93D6-A57122586ABEQ30827537-64D2D2B5-F690-4667-B1E2-E18E84624744Q30829469-72E5BF44-E48D-405E-80D8-B2BFB1371559Q30835794-48DBD1B9-5C10-4FE0-9552-5FC41F5FDAE3Q30836776-AD45AB9F-C8F9-4B10-9062-EC9A69E97C26Q30837496-89936BA5-7D0F-44D0-9D05-A0D9631107DBQ30853913-4D76E18F-1E20-41C6-A928-910DD7F32744Q30863128-528A244C-28EA-40BE-9324-C7E00B6727BEQ30873785-FA884BF2-4AAF-47C4-A8F0-5543D29C8B41Q30875888-2D48EFB0-FBBB-4A71-9F5D-07BF9086F258Q30891288-CF3BC43D-2184-48FB-B12E-2E75981D2919Q30921367-2D02D830-AC43-4BF1-A830-33891749DCCCQ30921563-F0A56679-BC63-4466-B4F8-1CA254152482
P2860
A review of uses of health care utilization databases for epidemiologic research on therapeutics.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A review of uses of health car ...... ogic research on therapeutics.
@ast
A review of uses of health car ...... ogic research on therapeutics.
@en
type
label
A review of uses of health car ...... ogic research on therapeutics.
@ast
A review of uses of health car ...... ogic research on therapeutics.
@en
altLabel
A review of uses of health car ...... logic research on therapeutics
@en
prefLabel
A review of uses of health car ...... ogic research on therapeutics.
@ast
A review of uses of health car ...... ogic research on therapeutics.
@en
P1476
A review of uses of health car ...... ogic research on therapeutics.
@en
P2093
Jerry Avorn
Sebastian Schneeweiss
P304
P356
10.1016/J.JCLINEPI.2004.10.012
P577
2005-04-01T00:00:00Z